215 related articles for article (PubMed ID: 16481094)
1. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
Schlenker B; Gratzke C; Reich O; Schorsch I; Seitz M; Stief CG
Eur Urol; 2006 Jun; 49(6):1075-8. PubMed ID: 16481094
[TBL] [Abstract][Full Text] [Related]
2. The use of Duloxetine in the treatment of male stress urinary incontinence.
Fink KG; Huber J; Würnschimmel E; Schmeller NT
Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
[TBL] [Abstract][Full Text] [Related]
3. Postprostatectomy established stress urinary incontinence treated with duloxetine.
Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
[TBL] [Abstract][Full Text] [Related]
4. Is HCl duloxetine effective in the management of urinary stress incontinence after radical prostatectomy?
Zahariou A; Papaioannou P; Kalogirou G
Urol Int; 2006; 77(1):9-12. PubMed ID: 16825808
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
7. The use of duloxetine for stress incontinence after prostatectomy.
Hotston MR; Hurley K; Patel S; Persad R
BJU Int; 2006 Oct; 98(4):916-7. PubMed ID: 16978296
[No Abstract] [Full Text] [Related]
8. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
Puyol M; Collado A
Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
[TBL] [Abstract][Full Text] [Related]
12. [Conservative treatment of male stress incontinence].
Buse S; Reitz A; Haferkamp A; Hohenfellner M
Urologe A; 2007 Mar; 46(3):240-3. PubMed ID: 17294152
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
Cardozo L; Drutz HP; Baygani SK; Bump RC
Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
[TBL] [Abstract][Full Text] [Related]
14. Update on duloxetine for the management of stress urinary incontinence.
Basu M; Duckett JR
Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
Alberti C
G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
[TBL] [Abstract][Full Text] [Related]
19. [Place of duloxetine in the treatment of stress urinary incontinence].
Rouprêt M; Richard F; Chartier-Kastler E
Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]